FOXM1 inhibitors such as the thiazole antibiotics siomycin A and thiostrepton [28, 29], induce the apoptosis of many types of cancer cells and have been approved by the Federal Drug Administration for animal use. This evidence concerns the gene FOXM1 and cancer.